With the help of artificial intelligence, computers are to simulate human thought processes. Machine learning is intended to support almost all medical specialties. But what is going on inside an AI algorithm, what are its decisions based on? Can you even entrust a medical diagnosis to a machine? Clarifying these questions remains a central aspect of AI research and development.
AI offers major opportunities to improve heart health, however, current use is fragmented. A new project aims to turn the technology's promise into better cardiovascular care.
AI-enabled spatial analysis can identify patterns in routine pathology slides that may help clinicians identify which patients with pancreatic cancer are at greater risk of recurrence after treatment and surgery, a new study finds.
Prostate cancer is the second most common cancer in men worldwide. As clinical guidelines increasingly recommend MRI before biopsy, prostate MRI has become a critical decision point in the diagnostic pathway. However, many imaging departments continue to face challenges such as long acquisition times, motion-sensitive exams, and labor-intensive post-processing.
PhantomX supplies a new generation of highly realistic phantoms for clinical imaging and AI in medical imaging. Advanced technologies, innovation and and science are used to create optimal solutions for clinical diagnostic workflows.
At CIRSE 2026, Precision IO presents Smart Seg AI for liver tumour segmentation and a new integration with GE HealthCare's Allia Moveo system for its Epione platform.
An AI tool built from Swedish national health registry data can predict hip fracture risk, and identify more at-risk individuals than current clinical screening practices, according to a new study.
Accurately diagnosing heart failure, aortic stenosis, mitral regurgitation, hypertrophic cardiomyopathy and many other conditions has never been more complex. Simultaneously, cardiologists are still expected to see more patients in less time. A newly CE-marked software could change that.
Discussion at the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026 recognises that artificial intelligence is an important part of clinical innovation, positioning it as a practical tool for improving speed, decision accuracy and transparency in drug development. Industry attention is increasingly shifting towards AI-driven data ecosystems, advanced analytics and intelligent…
On the way to a patient's “digital twin”: A novel, AI-powered virtual patient simulation system integrating multimodal data is designed to advance personalised cancer treatment.
Digital pathology and spatial omics could enable researchers to see how a tumor's different cell populations function, opening new perspectives for precision cancer therapy.
Perfectly viable medical devices disappearing from the European market, manufacturers walking away from the EU rather than navigating regulatory demands, patients losing access to products with long, well-documented safety records. The implementation process for the MDR and IVDR has been challenging, to put it mildly – and the journey is far from over. Ahead of the EAAR’s MDR/IVDR Summit…
A research team has developed a new method that directly optimizes the thickness of a 3D-printed lens to simultaneously and precisely stimulate multiple regions of the brain.
Using a two-step AI approach, researchers have developed a computationally efficient new method to detect and classify brain tumors from MRI scans more accurately.
How can innovative technology help solve the most urgent needs in medicine? At the Medical Taiwan 2026 health and care expo in Taipei, leading manufacturers, international experts and decision-makers offered a promising glimpse into the healthcare systems of tomorrow – technology-driven, AI-enhanced and highly efficient, but also personalised and deeply humane at its core.
A newly developed AI system analyzes surgeons’ techniques during prostate cancer surgery, helping identify the surgical movements associated with the best patient outcomes.
Point-of-care ultrasound, AI-assisted surgery, advanced biomaterials, and much more: At Medical Taiwan 2026, manufacturers once again presented a diverse range of solutions across the medical, health and care expo. We took a closer look at three noteworthy companies and their products on show.
How reliable is clinical speech-to-text AI? New research aims to not only answer this question but find specific solutions to advancing safe and reliable AI systems in medical documentation.
FLock.io has been spotlighted by the World Economic Forum (WEF)’s MINDS programme for two NHS trusts using its privacy-preserving AI to tackle major diseases. Both trusts use its federated learning platform to train clinical models while maintaining 100% data sovereignty.
Researchers have developed an AI technology that analyzes daily activity and environmental data from older adults to identify digital behavioral markers of cerebrovascular disease risk at home.
